HARVARD BIOSCIENCE, INC. Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price
HARVARD BIOSCIENCE, INC. (HBIO) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price of $26.31 per share for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice · last filed 2026-08-11
- HARVARD BIOSCIENCE, INC. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for the quarter ending 2026-03-31 was $32.10.
- HARVARD BIOSCIENCE, INC. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2025 was $3.20, a 31.91% decline from fiscal 2024.
- HARVARD BIOSCIENCE, INC. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2024 was $4.70, a 73.43% increase from fiscal 2023.
- HARVARD BIOSCIENCE, INC. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2023 was $2.71, a 2.17% decline from fiscal 2022.
- HARVARD BIOSCIENCE, INC. share-based compensation arrangements by share-based payment award, options, forfeitures in period, weighted average exercise price for fiscal 2022 was $2.77.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 9 month as first filed | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $26.31 10-Q · filed 2026-08-11 | ||||
| 2026-03-31 | $32.10 10-Q · filed 2026-05-12 | ||||
| 2025-12-31 | $3.20 10-K · filed 2026-03-13 | ||||
| 2025-09-30 | $3.20 10-Q · filed 2025-11-06 | ||||
| 2025-06-30 | $5.06 10-Q · filed 2025-08-11 | ||||
| 2024-12-31 | $4.70 10-K · filed 2026-03-13 | ||||
| 2024-09-30 | $5.51 10-Q · filed 2025-05-12 | $4.54 10-Q · filed 2024-11-08 | |||
| 2024-06-30 | $4.46 10-Q · filed 2024-08-08 | ||||
| 2023-12-31 | $2.71 10-K · filed 2025-03-14 | ||||
| 2022-12-31 | $2.77 10-K · filed 2024-03-07 | ||||
| 2020-09-30 | $3.43 10-Q · filed 2020-11-06 | ||||
| 2020-06-30 | $3.55 10-Q · filed 2020-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |